Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01292135 · COMPLETED
Trial details
- NCT number
- NCT01292135
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.